Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.Mikako Ogawa, Hideo Saji, Yasuhiro Magata et al.|PubMed|2006Cited by 121
Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Molecular Cancer Therapeutics|2013Cited by 46
Supplementary Figure Legends from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lilly Zhang et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0